PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
32.63
-0.18 (-0.55%)
At close: Jul 19, 2024, 4:00 PM
32.75
+0.12 (0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

PTC Therapeutics Statistics

Total Valuation

PTCT has a market cap or net worth of $2.50 billion. The enterprise value is $2.04 billion.

Market Cap 2.50B
Enterprise Value 2.04B

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, after market close.

Earnings Date Aug 1, 2024
Ex-Dividend Date n/a

Share Statistics

PTCT has 76.70 million shares outstanding. The number of shares has increased by 3.75% in one year.

Shares Outstanding 76.70M
Shares Change (YoY) +3.75%
Shares Change (QoQ) +1.32%
Owned by Insiders (%) 2.37%
Owned by Institutions (%) 113.75%
Float 56.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.70
Forward PS 3.80
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.20
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.03

Current Ratio 2.03
Quick Ratio 1.88
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.53

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -36.90%
Return on Capital (ROIC) n/a
Revenue Per Employee $932,219
Profits Per Employee -$582,132
Employee Count 995
Asset Turnover 0.59
Inventory Turnover 2.33

Taxes

Income Tax -66.60M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -18.47% in the last 52 weeks. The beta is 0.65, so PTCT's price volatility has been lower than the market average.

Beta (5Y) 0.65
52-Week Price Change -18.47%
50-Day Moving Average 34.60
200-Day Moving Average 28.10
Relative Strength Index (RSI) 45.84
Average Volume (20 Days) 955,102

Short Selling Information

The latest short interest is 5.60 million, so 7.30% of the outstanding shares have been sold short.

Short Interest 5.60M
Short Previous Month 7.35M
Short % of Shares Out 7.30%
Short % of Float 9.87%
Short Ratio (days to cover) 5.14

Income Statement

In the last 12 months, PTCT had revenue of $927.56 million and -$579.22 million in losses. Loss per share was -$7.68.

Revenue 927.56M
Gross Profit 861.48M
Operating Income -497.54M
Pretax Income -645.82M
Net Income -579.22M
EBITDA -245.30M
EBIT -503.13M
Loss Per Share -$7.68
Full Income Statement

Balance Sheet

The company has $884.81 million in cash and $421.44 million in debt, giving a net cash position of $463.37 million or $6.04 per share.

Cash & Cash Equivalents 884.81M
Total Debt 421.44M
Net Cash 463.37M
Net Cash Per Share $6.04
Equity (Book Value) -893.92M
Book Value Per Share -11.66
Working Capital 594.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$58.17 million and capital expenditures -$27.76 million, giving a free cash flow of -$85.92 million.

Operating Cash Flow -58.17M
Capital Expenditures -27.76M
Free Cash Flow -85.92M
FCF Per Share -$1.12
Full Cash Flow Statement

Margins

Gross margin is 92.88%, with operating and profit margins of -53.64% and -62.45%.

Gross Margin 92.88%
Operating Margin -53.64%
Pretax Margin -69.63%
Profit Margin -62.45%
EBITDA Margin -26.45%
EBIT Margin -54.24%
FCF Margin -9.26%

Dividends & Yields

PTCT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.75%
Shareholder Yield -3.75%
Earnings Yield -23.14%
FCF Yield -3.43%
Dividend Details

Analyst Forecast

The average price target for PTCT is $35.93, which is 10.11% higher than the current price. The consensus rating is "Hold".

Price Target $35.93
Price Target Difference 10.11%
Analyst Consensus Hold
Analyst Count 15
Revenue Growth Forecast (5Y) 6.99%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PTCT has an Altman Z-Score of -2.09 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.09
Piotroski F-Score 4